Target intelligence / Profile preview

Gastrointestinal tract ecological niche (GI niche)

Target
GI niche
Molecular classification
Other
01

Overview

The gastrointestinal (GI) tract ecological niche represents the complex, multi-kingdom ecosystem residing within the human digestive system, comprising the gut microbiota, host epithelial lining, and the mucosal immune system. This niche is defined by distinct physiological gradients, including oxygen tension, pH levels, and nutrient availability, which shape the composition and metabolic output of the resident microbial communities (NIH, 2023). Biologically, this environment is essential for the fermentation of non-digestible carbohydrates, the synthesis of vitamins (such as K and B12), and the maturation of the host's immune response (Nature Reviews Microbiology, 2020). Dysregulation of this niche, or dysbiosis, is a hallmark of various pathologies, including inflammatory bowel disease (IBD), metabolic syndrome, and increased susceptibility to pathogens like Clostridioides difficile (Cell, 2019). Therapeutic strategies targeting this niche do not typically interact with a single receptor but rather aim to shift the entire ecological state through the use of antibiotics, probiotics, prebiotics, or fecal microbiota transplantation (FMT) to restore functional homeostasis (PubMed, 2021).

Other names
Gut microbiomeIntestinal ecosystemGastrointestinal environmentGut microbiota nicheIntestinal microenvironment
02

Mechanism of action

Modulation of the microbial ecosystem to restore eubiosis and host-microbe homeostasis.

03

Biological functions

Metabolic homeostasisImmune system modulationNutrient absorptionPathogen colonization resistanceVitamin synthesisFermentation of non-digestible carbohydrates
04

Disease associations

Inflammatory bowel disease (IBD)Irritable bowel syndrome (IBS)ObesityClostridioides difficile infectionMetabolic syndromeColorectal cancer
05

Safety considerations

Risk of opportunistic infectionsTransfer of antibiotic resistance genesSystemic translocation of microbesLong-term ecological instabilityUnpredictable community shifts
06

Interacting drugs

Vancomycin

4 more in the full profile.

07

Biomarkers

Microbial alpha-diversityFirmicutes/Bacteroidetes ratioShort-chain fatty acid (SCFA) levelsFecal calprotectinMicrobial beta-diversity

Beyond the preview

Go deeper on Gastrointestinal tract ecological niche (GI niche).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal tract ecological niche (GI niche).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call